Related Experiment Video
Updated: Jan 11, 2026

Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry
Published on: June 22, 2017
Divergent roles of macrophage subsets, FoxP3, and IL-17A in HSV-1-induced CNS pathology
Ujjaldeep Jaggi1, Satoshi Hirose1, Shaohui Wang1
1Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, CSMC, Los Angeles, California, United States of America.
Abstract:
As a central player in neuroinflammation, macrophages play multifaceted roles such as antigen presentation, phagocytosis, production of cytokines/chemokines, and growth/neurotrophic factors. Our previous work demonstrated that ocular infection with a recombinant herpes simplex virus type 1 (HSV-1) expressing interleukin-2 (HSV-IL-2) causes CNS pathology, independently of macrophages in different mouse strains. In contrast, wild type (WT) HSV-1 infection induces CNS demyelination in a macrophage-dependent manner. Therefore, in this study, we have two mouse models infected with either HSV-IL-2 or WT HSV-1 to examine the outcome of the absence of IL-17A, FoxP3, macrophages, or combined macrophage and FoxP3 depletion on CNS demyelination. Our data reveals several notable findings: deletion of FoxP3 alone in mice infected with either HSV-IL-2 or WT HSV-1 did not induce CNS demyelination. However, combined depletion of macrophages and FoxP3 in HSV-IL-2-infected mice triggered CNS demyelination, whereas the same combined depletion in WT HSV-1 infection prevented demyelination. Additionally, macrophage depletion alone in WT HSV-1-infected mice induced CNS demyelination, highlighting the non-redundant protective role of macrophages in this model. To further elucidate the role of macrophages in CNS demyelination, we investigated which macrophage subtype is responsible for modulating demyelination using M1 and M2 knockout mice. Our results indicate that M1 macrophages are key drivers of plaque formation, as infection with either HSV-IL-2 or WT HSV-1 failed to cause CNS demyelination in the absence of M1 macrophages. Conversely, M2-deficient mice exhibited demyelination, suggesting a protective role for M2 macrophages. Finally, depletion of macrophages in IL-17A-deficient mice infected with HSV-IL-2 did not restore CNS demyelination, indicating that, unlike the macrophage-FoxP3 double depletion in the HSV-IL-2 model, the IL-17A-macrophage absence is beneficial. Taken together, these findings highlight the distinct and non-redundant roles of FoxP3, IL-17A, and macrophage subsets in modulating CNS pathology during HSV-1 infection and suggest that targeting M1 macrophage activation may be a promising strategy for limiting demyelination.
Insights
Herpes simplex virus type 1 (HSV-1) infection outcomes in the central nervous system (CNS) depend on macrophage roles. Targeting M1 macrophages may prevent HSV-1-induced demyelination.
Area of Science:
- Neuroimmunology
- Virology
- Pathology
Background:
- Macrophages are key in neuroinflammation, with roles in antigen presentation and cytokine production.
- Herpes simplex virus type 1 (HSV-1) infection can cause central nervous system (CNS) pathology.
- While wild-type (WT) HSV-1 induces CNS demyelination dependent on macrophages, a recombinant HSV-1 expressing interleukin-2 (HSV-IL-2) causes pathology independently of macrophages.
Purpose of the Study:
- To investigate the roles of IL-17A, FoxP3, and macrophages in HSV-1-induced CNS demyelination.
- To determine the specific contributions of macrophage subsets (M1 and M2) in modulating demyelination.
- To explore potential therapeutic strategies targeting macrophage activation for preventing CNS demyelination.
Main Methods:
- Utilized two mouse models: one infected with HSV-IL-2 and another with WT HSV-1.
- Employed genetic depletion strategies for FoxP3, macrophages, and combined macrophage/FoxP3 depletion.
- Investigated demyelination in M1 and M2 macrophage knockout mice, as well as IL-17A-deficient mice.
Main Results:
- Combined macrophage and FoxP3 depletion triggered demyelination in HSV-IL-2 infection but prevented it in WT HSV-1 infection.
- Macrophage depletion alone in WT HSV-1 infection induced demyelination, highlighting their protective role.
- M1 macrophages were identified as drivers of demyelination, while M2 macrophages appeared protective.
- Absence of IL-17A with macrophage depletion was beneficial in HSV-IL-2 infection.
Conclusions:
- FoxP3, IL-17A, and macrophage subsets play distinct, non-redundant roles in modulating CNS pathology during HSV-1 infection.
- M1 macrophage activation is a critical factor in HSV-1-induced demyelination.
- Targeting M1 macrophage activation presents a potential therapeutic strategy for limiting CNS demyelination.

